PSIP1 and breast carcinoma: Daugaard et al. [17] reported elevated LEDGF/p75 transcript expression in human breast and bladder cancers, and that its ectopic overexpression in breast cancer cells protected against drug-induced lysosomal cell death and increased the tumorigenic potential of the cancer cells in murine models.